First recommended by a Trump-appointed FDA leader, multiple administrations have collaborated to snuff out this issue that ...
The agencies are charged with making decisions that touch the lives of every American and are the source of crucial ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...
The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what ...
Fast-track status will allow Solid Biosciences to have more frequent meetings with the FDA throughout the treatment-development process and, potentially, get the product to patients faster than would ...
Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation ...
CHARLESTOWN, Mass. - Solid Biosciences Inc. (NASDAQ:SLDB), a $130.65 million market cap biotechnology company, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued ...
In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...